NCT00991198

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 49 (actual)
• Sponsor: Aria Aesthetics Inc. · Industry
• Sex: Female
• Age: 25 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.

Conditions

• Rosacea
• Acne Vulgaris
• Atopic Dermatitis
• Seborrheic Dermatitis

Interventions

Type	Name	Description
DRUG	Topical oxygen	0.5% concentration of Topical oxygen
DRUG	Topical oxygen	0.25% concentration topical oxygen
DRUG	placebo	no O2

Timeline

• Start date: 2009-09-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2009-10-07
• Last updated: 2011-06-08

Locations

1 site across 1 country: United States